# LEVETIRACETAM
> **ANDA209474** · Abbreviated New Drug Application (Generic) · Sponsor: PRINSTON INC · Approved 2022-03-28
## Drug
- **FDA Application Number:** ANDA209474
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVETIRACETAM
- **Generic name:** LEVETIRACETAM
- **Active ingredients:** LEVETIRACETAM
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** PRINSTON INC
- **Manufacturer:** Solco Healthcare US, LLC
- **First approval:** 2022-03-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209474)
---
*MORVS · CC0 1.0*